Review



alphafold3 platform  (Deepmind Technologies Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Deepmind Technologies Ltd alphafold3 platform
    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using <t>AlphaFold3</t> to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001
    Alphafold3 Platform, supplied by Deepmind Technologies Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alphafold3 platform/product/Deepmind Technologies Ltd
    Average 86 stars, based on 1 article reviews
    alphafold3 platform - by Bioz Stars, 2026-05
    86/100 stars

    Images

    1) Product Images from "ADAMDEC1-driven CCL2-CCR2-PD-1 axis in esophageal squamous cell carcinoma: a dual threat of O-GlcNAcylation and m 6 A methylation in neoadjuvant therapy resistance and immune evasion"

    Article Title: ADAMDEC1-driven CCL2-CCR2-PD-1 axis in esophageal squamous cell carcinoma: a dual threat of O-GlcNAcylation and m 6 A methylation in neoadjuvant therapy resistance and immune evasion

    Journal: Cellular Oncology

    doi: 10.1007/s13402-026-01204-7

    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using AlphaFold3 to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001
    Figure Legend Snippet: OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using AlphaFold3 to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001

    Techniques Used: Binding Assay, Immunohistochemical staining, Staining, Marker, Expressing, Western Blot, Modification, Knock-Out, Control, Co-Immunoprecipitation Assay, Biomarker Discovery, Knockdown, Over Expression, Flow Cytometry, Cell Culture, In Vivo



    Similar Products

    alphafold3 platform  (Deepmind Technologies Ltd)
    86
    Deepmind Technologies Ltd alphafold3 platform
    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using <t>AlphaFold3</t> to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001
    Alphafold3 Platform, supplied by Deepmind Technologies Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alphafold3 platform/product/Deepmind Technologies Ltd
    Average 86 stars, based on 1 article reviews
    alphafold3 platform - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    alphafold3 af3 platform  (Deepmind Technologies Ltd)
    86
    Deepmind Technologies Ltd alphafold3 af3 platform
    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using <t>AlphaFold3</t> to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001
    Alphafold3 Af3 Platform, supplied by Deepmind Technologies Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alphafold3 af3 platform/product/Deepmind Technologies Ltd
    Average 86 stars, based on 1 article reviews
    alphafold3 af3 platform - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    alphafold3 online platform  (Deepmind Technologies Ltd)
    90
    Deepmind Technologies Ltd alphafold3 online platform
    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using <t>AlphaFold3</t> to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001
    Alphafold3 Online Platform, supplied by Deepmind Technologies Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alphafold3 online platform/product/Deepmind Technologies Ltd
    Average 90 stars, based on 1 article reviews
    alphafold3 online platform - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using AlphaFold3 to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001

    Journal: Cellular Oncology

    Article Title: ADAMDEC1-driven CCL2-CCR2-PD-1 axis in esophageal squamous cell carcinoma: a dual threat of O-GlcNAcylation and m 6 A methylation in neoadjuvant therapy resistance and immune evasion

    doi: 10.1007/s13402-026-01204-7

    Figure Lengend Snippet: OGT is involved in ADAMDEC1-mediated regulation of the CCL2-CCR2-PD-1 signaling axis. ( A ) Molecular docking simulation using AlphaFold3 to predict binding modes and key amino acid interactions between ADAMDEC1 and OGT. ( B ) Immunohistochemical staining of ADAMDEC1, OGT, and RL2 (O-GlcNAcylation marker) in clinical ESCA tissues, with Pearson correlation analysis of protein expression. ( C ) Western blot detection of OGT protein and O-GlcNAc modification levels in ADAMDEC1-knockout (ADAMDEC1-KO) vs. control ESCA-PDOs. ( D ) Co-immunoprecipitation (Co-IP) assay using anti-ADAMDEC1 antibody to validate physical interaction between ADAMDEC1 and OGT in ESCA-PDOs, followed by Western blot analysis. ( E ) Cycloheximide (CHX) chase assay to measure OGT protein half-life in ADAMDEC1-KO ESCA-PDOs, with protein levels detected by Western blot at indicated time points. ( F ) Treatment of ADAMDEC1-KO ESCA-PDOs with proteasome inhibitor MG132, followed by Western blot to assess OGT protein level recovery. ( G ) Validation of ESCA-PDOs with lentiviral-mediated ADAMDEC1 knockdown and/or OGT overexpression by Western blot. ( H ) Western blot analysis of CCL2, and CCR2 protein levels in shADAMDEC1 ESCA-PDOs with OGT overexpression. ( I ) Flow cytometry detection of PD-1 expression on CD8 + T cells co-cultured with ESCA-PDOs. Un-paired Student’s t-test were used for in vivo experiments. n = 5, *** p < 0.001

    Article Snippet: The protein amino acid sequences were retrieved from the UniProt database ( https://www.uniprot.org/ ) and processed through the AlphaFold3 platform ( https://deepmind.google/technologies/alphafold/alphafold-server/ ) for predicting interaction patterns.

    Techniques: Binding Assay, Immunohistochemical staining, Staining, Marker, Expressing, Western Blot, Modification, Knock-Out, Control, Co-Immunoprecipitation Assay, Biomarker Discovery, Knockdown, Over Expression, Flow Cytometry, Cell Culture, In Vivo